Cumberland Pharmaceuticals's market cap is currently $83.55M. The company's EPS TTM is $-0.769; its P/E ratio is ―; Cumberland Pharmaceuticals is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 39.55M	$ 42.01M	$ 35.99M	$ 37.44M	$ 34.39M
Gross Profit	$ 33.49M	$ 32.89M	$ 27.17M	$ 28.79M	$ 26.97M
Operating Income	$ -6.21M	$ -5.70M	$ -7.68M	$ -6.38M	$ -9.29M
EBITDA	$ 153.32K	$ 332.92K	$ -857.83K	$ -1.56M	$ -4.64M
Net Income	$ -6.28M	$ -5.65M	$ -5.60M	$ -6.63M	$ -9.21M
Balance Sheet
Cash & Short-Term Investments	$ 18.32M	$ 19.76M	$ 27.04M	$ 24.75M	$ 28.21M
Total Assets	$ 81.78M	$ 92.93M	$ 84.46M	$ 96.46M	$ 104.55M
Total Debt	$ 18.43M	$ 20.96M	$ 16.06M	$ 17.08M	$ 21.50M
Net Debt	$ 106.86K	$ 1.20M	$ -10.98M	$ -7.68M	$ -6.72M
Total Liabilities	$ 52.52M	$ 56.95M	$ 41.86M	$ 49.59M	$ 53.46M
Stockholders' Equity	$ 29.60M	$ 36.27M	$ 42.81M	$ 46.99M	$ 51.12M
Cash Flow
Free Cash Flow	$ 5.64M	$ 6.38M	$ 5.99M	$ 3.30M	$ 2.04M
Operating Cash Flow	$ 6.09M	$ 8.45M	$ 6.34M	$ 5.42M	$ 3.06M
Investing Cash Flow	$ -105.69K	$ -13.67M	$ -501.89K	$ -1.76M	$ 2.30M
Financing Cash Flow	$ -7.42M	$ -2.06M	$ -3.55M	$ -7.12M	$ -5.08M

Currency in USD

Cumberland Pharmaceuticals Earnings and Revenue History

Income Statement >

Cumberland Pharmaceuticals Debt to Assets

Balance Sheet >

Cumberland Pharmaceuticals Cash Flow

Cash Flow >

Cumberland Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing